Skip to main content
NCBI home page
Bulletin of the New York Academy of Medicine logoLink to Bulletin of the New York Academy of Medicine
. 1980 Oct;56(8):703–714.

Drugs in the elderly.

M M Reidenberg
PMCID: PMC1805189  PMID: 6932241

Full text

PDF
703

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asberg M. Individualization of treatment with tricyclic compounds. Med Clin North Am. 1974 Sep;58(5):1083–1091. [PubMed] [Google Scholar]
  2. Bender A. D. Effect of age on intestinal absorption: implications for drug absorption in the elderly. J Am Geriatr Soc. 1968 Dec;16(12):1331–1339. doi: 10.1111/j.1532-5415.1968.tb02776.x. [DOI] [PubMed] [Google Scholar]
  3. Brown R. D., Feldman A. M. Pharmacology of hearing and ototoxicity. Annu Rev Pharmacol Toxicol. 1978;18:233–252. doi: 10.1146/annurev.pa.18.040178.001313. [DOI] [PubMed] [Google Scholar]
  4. Crooks J., O'Malley K., Stevenson I. H. Pharmacokinetics in the elderly. Clin Pharmacokinet. 1976;1(4):280–296. doi: 10.2165/00003088-197601040-00003. [DOI] [PubMed] [Google Scholar]
  5. DAVIES D. F., SHOCK N. W. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest. 1950 May;29(5):496–507. doi: 10.1172/JCI102286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ewy G. A., Kapadia G. G., Yao L., Lullin M., Marcus F. I. Digoxin metabolism in the elderly. Circulation. 1969 Apr;39(4):449–453. doi: 10.1161/01.cir.39.4.449. [DOI] [PubMed] [Google Scholar]
  7. Friedlander I. R. Ototoxic drugs and the detection of ototoxicity. N Engl J Med. 1979 Jul 26;301(4):213–214. [PubMed] [Google Scholar]
  8. Giles H. G., MacLeod S. M., Wright J. R., Sellers E. M. Influence of age and previous use of diazepam dosage required for endoscopy. Can Med Assoc J. 1978 Mar 4;118(5):513–514. [PMC free article] [PubMed] [Google Scholar]
  9. Greenblatt D. J., Allen M. D., Harmatz J. S., Shader R. I. Diazepam disposition determinants. Clin Pharmacol Ther. 1980 Mar;27(3):301–312. doi: 10.1038/clpt.1980.40. [DOI] [PubMed] [Google Scholar]
  10. Hotraphinyo K., Triggs E. J., Maybloom B., Maclaine-Cross A. Warfarin sodium: steady-state plasma levels and patient age. Clin Exp Pharmacol Physiol. 1978 Mar-Apr;5(2):143–149. doi: 10.1111/j.1440-1681.1978.tb00664.x. [DOI] [PubMed] [Google Scholar]
  11. Hull S. M., Mackintosh A. Discontinuation of maintenance digoxin therapy in general practice. Lancet. 1977 Nov 19;2(8047):1054–1055. doi: 10.1016/s0140-6736(77)91886-4. [DOI] [PubMed] [Google Scholar]
  12. Hurwitz N. Predisposing factors in adverse reactions to drugs. Br Med J. 1969 Mar 1;1(5643):536–539. doi: 10.1136/bmj.1.5643.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Jones B. R., Baran A., Reidenberg M. M. Evaluating patients' warfarin requirements. J Am Geriatr Soc. 1980 Jan;28(1):10–12. doi: 10.1111/j.1532-5415.1980.tb00116.x. [DOI] [PubMed] [Google Scholar]
  14. Kessler K. M., Lowenthal D. T., Warner H., Gibson T., Briggs W., Reidenberg M. M. Quinidine elimination in patients with congestive heart failure or poor renal function. N Engl J Med. 1974 Mar 28;290(13):706–709. doi: 10.1056/NEJM197403282901303. [DOI] [PubMed] [Google Scholar]
  15. Koch-Weser J. The serum level approach to individualization of drug dosage. Eur J Clin Pharmacol. 1975 Oct 10;9(1):1–8. doi: 10.1007/BF00613423. [DOI] [PubMed] [Google Scholar]
  16. Lely A. H., van Enter Ch. Non-cardiac symptoms of digitalis intoxication. Am Heart J. 1972 Feb;83(2):149–152. doi: 10.1016/0002-8703(72)90132-9. [DOI] [PubMed] [Google Scholar]
  17. Morris L. A., Halperin J. A. Effects of written drug information on patient knowledge and compliance: a literature review. Am J Public Health. 1979 Jan;69(1):47–52. doi: 10.2105/ajph.69.1.47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Redolfi A., Borgogelli E., Lodola E. Blood level of cimetidine in relation to age. Eur J Clin Pharmacol. 1979 May 21;15(4):257–261. doi: 10.1007/BF00618514. [DOI] [PubMed] [Google Scholar]
  19. Reidenberg M. M., Levy M., Warner H., Coutinho C. B., Schwartz M. A., Yu G., Cheripko J. Relationship between diazepam dose, plasma level, age, and central nervous system depression. Clin Pharmacol Ther. 1978 Apr;23(4):371–374. doi: 10.1002/cpt1978234371. [DOI] [PubMed] [Google Scholar]
  20. Reidenberg M. M. The binding of drugs to plasma proteins and the interpretation of measurements of plasma concentrations of drugs in patients with poor renal function. Am J Med. 1977 Apr;62(4):466–470. doi: 10.1016/0002-9343(77)90398-9. [DOI] [PubMed] [Google Scholar]
  21. Richey D. P., Bender A. D. Pharmacokinetic consequences of aging. Annu Rev Pharmacol Toxicol. 1977;17:49–65. doi: 10.1146/annurev.pa.17.040177.000405. [DOI] [PubMed] [Google Scholar]
  22. Roth G. S. Hormone receptor changes during adulthood and senescence: significance for aging research. Fed Proc. 1979 Apr;38(5):1910–1914. [PubMed] [Google Scholar]
  23. Routledge P. A., Chapman P. H., Davies D. M., Rawlins M. D. Factors affecting warfarin requirements. A prospective population study. Eur J Clin Pharmacol. 1979 Jun 12;15(5):319–322. doi: 10.1007/BF00558434. [DOI] [PubMed] [Google Scholar]
  24. Triggs E. J., Nation R. L., Long A., Ashley J. J. Pharmacokinetics in the elderly. Eur J Clin Pharmacol. 1975;8(1):55–62. doi: 10.1007/BF00616415. [DOI] [PubMed] [Google Scholar]
  25. Vestal R. E., Wood A. J., Shand D. G. Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther. 1979 Aug;26(2):181–186. doi: 10.1002/cpt1979262181. [DOI] [PubMed] [Google Scholar]
  26. Volpe B. T., Soave R. Formed visual hallucinations as digitalis toxicity. Ann Intern Med. 1979 Dec;91(6):865–866. doi: 10.7326/0003-4819-91-6-865. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES